San Francisco, CA. – ANGANY delegates attended this conference on the latest developments in vaccines and immunotherapy. ANGANY held a presentation titled: “Bioparticle-Potentiated Immunotherapy: Introducing a new bioparticle platform /…
Read More
News
Lévis, QC. – ANGANY is starting operations at this unit set up at AgBioCentre on Mgr Bourget Street in Lévis. This will further progress of process development to its “industrial”…
presented. PhD student Stefanie Busold from Pr. Ronald van Ree’s lab at Amsterdam University Medical Centers presented a scientific poster titled: “Towards Tolerance: Targeting dendritic cells to combat allergic disease.”…
This marks ANGANY’s first corporate sponsorship of a scientific meeting. The International Symposium on Molecular Allergy is a specialty meeting of the European Academy of Allergy and Clinical Immunology held…
Montreal, QC. – Delegates from ANGANY’s executive board attended this forum at the invitation of BCF Business Law.
ANGANY CEO Dr. Louis-Philippe Vézina is pleased to announce the collaboration of Pr. Favrot of the University of Zurich. Pr. Favrot is providing ANGANY with sophisticated insights regarding CAD, an…
Lisbon, Portugal. – ANGANY CEO Dr. Louis-Philippe Vézina and other members of the leadership team of the company attended the European Academy of Allergy and Clinical Immunology’s annual meeting. This…
Montreal, QC – Forum stratégie que le financement d’entreprises ANGANY representatives attended this didactic and networking activity held simultaneously in Montreal and in Quebec City. Of note, the presentation made…
Amsterdam, NL. – World renowned Pr. Van Ree heads the Laboratory for Allergy Research at Amsterdam UMC, Universitair Medische Centra. Pr. Van Ree presents a distinguished course of professional accomplishments…